|
The content on or accessible through Medpedia.com is for informational purposes only. Medpedia is not a substitute for professional advice or expert medical services from a qualified health professional.
Read more
|
Transferrin CRM107
There are currently no Lead Editors of this article.
Ask a Question on This Topic
Important Resources for Transferrin CRM107:
The information on this page is seed content provided by an organization. Please help improve this Article by adding to it. If you are a physician or PhD, learn how to edit. If you are anyone else, learn how to suggest changes.
This is a "stub" page. Help expand Medpedia's knowledgebase by Editing or Suggesting Changes to make it more complete.
A substance being studied in the treatment of brain tumors. Transferrin-CRM107 is made by linking a diphtheria toxin to transferrin, a protein that binds to fast growing cells, such as tumor cells. The diphtheria toxin then kills the tumor cells. Transferrin-CRM107 is a type of immunotoxin.
To suggest changes to this page, you must create an account on Medpedia.